The upside potential for this biotech company is at over 75% with a $9.25 price target!

Zack's Small Cap Research thinks this company is "underpriced" and gave it a $9.25 price target! ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ Unsubscribe A Message from Huge Alerts Zack’s Small Cap Research thinks this company is “underpriced” and gave it a $9.25 price target! Regenerative medicine is the future, and it comes as no surprise that the biotech space is all over it. Who will be the leading biotech companies utilizing regenerative medicine in the future? That’s the million-dollar question but this emerging company has explosive growth potential ahead in this rising arena. The company is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. These allografts are not just any allografts. They are best-in-class perinatal tissue allografts! The company is focused on the diabetic wound care market and the advanced wound care market: two multi-billion-dollar markets that could equate to explosive revenues all while helping patients.  Recently the company reported a stellar third quarter where net revenue grew over 200% and gross profit grew 79%! Revenues are skyrocketing, the company has secured a CMS Q code, there are game-changing partnerships, a successful capital raise, and the start of a crucial clinical trial for diabetic foot ulcers… this all reads like a recipe for tremendous shareholder value! Learn how this little-known company may soon become the next biotech darling!

This message is a paid advertisement sent on behalf of Huge Alerts, a third-party advertiser of MarketBeat. Why did I receive this email?     This message is a paid advertisement for BioStem Technologies Inc. (OTC: BSEM) from Sideways Frequency and Huge Alerts. American Consumer News, LLC dba MarketBeat receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $12,600. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Sideways Frequency or Huge Alerts. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BioStem Technologies Inc. (OTC: BSEM) on Huge Alerts' website for additional information about the relationship between Huge Alerts and BioStem Technologies Inc. (OTC: BSEM).     If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.   © 2006-2024 American Consumer News, LLC dba MarketBeat. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: Buy This Stock for AI Tidal Wave (not NVDA)